Ou Bai

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Venues

Jilin University First Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Jilin University First Hospital Sep 15 2000

China

No.71 Xinmin street :: tumor center

Publications

Zhaoxia Li, Wei Guo, Yangzhi Zhao, Haotian Wang, Jing Guo, Zhe Li, Bowen Wang, Luming Cao, Jihong Xu, Ken H Young, Ou Bai
Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study. Cancer medicine 13 (10) (2024)
Zhaoxia Li, Wei Guo, Yangzhi Zhao, Haotian Wang, Jing Guo, Zhe Li, Bowen Wang, Luming Cao, Jihong Xu, Ken H Young, Ou Bai
Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study. Cancer medicine 13 (10) (2024)
Zhumei Zhan, Wei Guo, Jia Li, Xin Wan, Jing Guo, Ou Bai
Clinical features and prognosis of double primary malignant neoplasms in patients with non-hodgkin lymphoma. Discover. Oncology 14 (1) (2023)
Zhumei Zhan, Wei Guo, Xin Wan, Ou Bai
Second primary malignancies in non-Hodgkin lymphoma: epidemiology and risk factors. Annals of hematology 102 (2) (2023)
Zhumei Zhan, Wei Guo, Xin Wan, Ou Bai
Second primary malignancies in non-Hodgkin lymphoma: epidemiology and risk factors. Annals of hematology 102 (2) (2023)
Zhumei Zhan, Wei Guo, Jia Li, Xin Wan, Jing Guo, Ou Bai
Clinical features and prognosis of double primary malignant neoplasms in patients with non-hodgkin lymphoma. Discover. Oncology 14 (1) (2023)
Zhumei Zhan, Wei Guo, Jia Li, Xin Wan, Jing Guo, Ou Bai
Clinical features and prognosis of double primary malignant neoplasms in patients with non-hodgkin lymphoma. Discover. Oncology 14 (1) (2023)
Zhumei Zhan, Wei Guo, Xin Wan, Ou Bai
Second primary malignancies in non-Hodgkin lymphoma: epidemiology and risk factors. Annals of hematology 102 (2) (2023)
Zhumei Zhan, Wei Guo, Jia Li, Xin Wan, Jing Guo, Ou Bai
Clinical features and prognosis of double primary malignant neoplasms in patients with non-hodgkin lymphoma. Discover. Oncology 14 (1) (2023)
Zhumei Zhan, Wei Guo, Xin Wan, Ou Bai
Second primary malignancies in non-Hodgkin lymphoma: epidemiology and risk factors. Annals of hematology (2023)
Weihan Sun, Wei Guo, Zhiyi Liu, Sennan Qiao, Ziming Wang, Jiayu Wang, Lingxuan Qu, Liang Shan, Fei Sun, Shu-Ping Xu, Ou Bai, Chongyang Liang
Direct MYD88 L265P gene detection for diffuse large B-cell lymphoma (DLBCL) via a miniaturised CRISPR/dCas9-based sensing chip. Lab on a chip 22 (4) (2022)
Xiaomeng Feng, Wei Guo, Yinping Wang, Jia Li, Yangzhi Zhao, Limei Qu, Xu Yan, Junna Li, Qiang Guo, Ken H Young, Ou Bai
The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone in Untreated PTCL: A Real-World, Retrospective Study. Advances in therapy (2021)
Xinxing Huang, Ken H Young, Wei Guo, Yinping Wang, Xueju Wang, Yanfeng Xi, Lifen Wang, Ou Bai
Identification of hepatitis B virus aetiologic antigens, HBx and Pre-S2, in diffuse large B-cell lymphoma. Journal of viral hepatitis 27 (9) (2020)
Zhihe Liu, Siyun Li, Wei Guo, Yinping Wang, Ming Wang, Ou Bai
MYC Gene Rearrangements Are Closely Associated with Poor Survival of Diffuse Large B Cell Lymphoma with Hepatitis B Virus Infection. BioMed research international 2017 (2017)

Ou Bai.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ou Bai